Search research articles
Contact Us
Filters
Showing results (71-80 of 167) with videos related to
Page
of 17
Sort By:
Investigational New Drugs
|
October 18, 2011
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors
Andrea Wang-Gillam, William P Tew, Mace L Rothenberg, et al.
The Journal of Sexual Medicine
|
March 7, 2012
The bar sinister: does handlebar level damage the pelvic floor in female cyclists?
Sarah N Partin, Kathleen A Connell, Steven Schrader, et al.
Advances in Radiation Oncology
|
March 5, 2021
Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
Comron Hassanzadeh, Soumon Rudra, Ani Bommireddy, et al.
Bone
|
July 5, 2015
Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology
Philippe Zysset, Dieter Pahr, Klaus Engelke, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2012
Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial
Jacques P Brown, Christian Roux, Ove Törring, et al.
Headache
|
June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
Cancer Research
|
August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models
Yu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Annals of Surgery
|
June 21, 2014
Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study
Stephanie T Chang, Dennis C Nguyen, Constantine Raptis, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma
May Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Journal of Gastrointestinal Oncology
|
March 17, 2020
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma
Patrick Grierson, Andrea Teague, Rama Suresh, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 167) with videos related to
Sort By:
Page
of 17
Investigational New Drugs
|
October 18, 2011
A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors
Andrea Wang-Gillam, William P Tew, Mace L Rothenberg, et al.
The Journal of Sexual Medicine
|
March 7, 2012
The bar sinister: does handlebar level damage the pelvic floor in female cyclists?
Sarah N Partin, Kathleen A Connell, Steven Schrader, et al.
Advances in Radiation Oncology
|
March 5, 2021
Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
Comron Hassanzadeh, Soumon Rudra, Ani Bommireddy, et al.
Bone
|
July 5, 2015
Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology
Philippe Zysset, Dieter Pahr, Klaus Engelke, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 31, 2012
Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial
Jacques P Brown, Christian Roux, Ove Törring, et al.
Headache
|
June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
Stewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
Cancer Research
|
August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models
Yu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Annals of Surgery
|
June 21, 2014
Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study
Stephanie T Chang, Dennis C Nguyen, Constantine Raptis, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma
May Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Journal of Gastrointestinal Oncology
|
March 17, 2020
Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma
Patrick Grierson, Andrea Teague, Rama Suresh, et al.
Page
of 17